SCHEMBL9949138

SCHEMBL9949138

CC1CCCCC1C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA4 P22748 1/20 0.39
EPHX1 P07099 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19478859 0.94 CA1 (0.33) CA1CA2CA4
SCHEMBL16191262 0.82 CA1 (0.39) CA1CA2CA4EPHX1
SCHEMBL18676250 0.81
SCHEMBL29342051 0.81 CA1 (0.31) CA1CA2CA4EPHX1
SCHEMBL9900218 0.81 ALDH1A1 (0.31) EPHX1
SCHEMBL20319026 0.79
SCHEMBL18734252 0.78 CA1 (0.36) CA1CA2CA4EPHX1
SCHEMBL10005776 0.78 CA1 (0.42) CA1CA2CA4EPHX1
SCHEMBL8620887 0.76 CA1 (0.40) CA1CA2CA4
SCHEMBL29342647 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11655371-B2 Color material dispersion liquid, color resin composition, color filter, liquid crystal display device, and light-emitting display device DAI NIPPON PRINTING CO., LTD. (JP) 2023-05-23 US disclosed
US-20210324200-A1 COLOR MATERIAL DISPERSION LIQUID, COLOR RESIN COMPOSITION, COLOR FILTER, LIQUID CRYSTAL DISPLAY DEVICE, AND LIGHT-EMITTING DISPLAY DEVICE DAI NIPPON PRINTING CO., LTD. (JP) 2021-10-21 US disclosed
EP-2479159-A1 PREPARATION METHOD FOR COMPOUND PROVIDED WITH DOUBLE BOND Sumitomo Chemical Co., Ltd (JP) 2012-07-25 EP disclosed
US-20120165587-A1 Method for Producing a Compound with a Double Bond SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120165587-A1 Method for Producing a Compound with a Double Bond ADH1C, ADH1A, ADH5 CA1 1145/4885CA2 2748/4885CA4 2379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.